Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows (original) (raw)
Posted 2026-05-06, Times Argus
BILLERICA, Mass.--(BUSINESS WIRE)--May 6, 2026-- ......read full story
Ask about this article
Answer for your question of the article will be displayed here ...
Related News
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
Times Argus 2026-03-02, 14:16
Quanterix Releases Financial Results for the First Quarter of 2026
The Milton Standard Journal 2026-05-07, 04:49
Tempus Announces Strategic Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Clinical Differentiation ...
The Galveston Daily News 2026-03-25, 13:49
Related News
Quanterix Corporation Announces Date of 2026 Annual Meeting
The Galveston Daily News
2026-03-27, 20:29
Quanterix Announces Planned Transition of Chief Financial Officer
The Galveston Daily News
2026-05-13, 00:49
Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics
Caledonian Record
2026-06-04, 13:56
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
Caledonian Record
2026-03-02, 22:15
Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI
Times Argus
2026-05-26, 12:52
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Milton Standard Journal
2026-05-26, 21:54
Bruker Announces Appointment of Thierry Bernard to its Board of Directors
The Milton Standard Journal
2026-04-01, 12:26